Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-03-16

Clinical Trial Update: Effectiveness of Mineral Trioxide Aggregate and Platelet Rich Fibrin Along With Biodentine. . [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating mineral trioxide aggregate, platelet rich fibrin, and Biodentine for irreversible pulpitis; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biodentine (tricalcium silicate cement)
  • Mineral Trioxide Aggregate (mineral trioxide aggregate)
  • Platelet Rich Fibrin (platelet-rich fibrin)

Snippet

Sponsor: Maharishi Markendeswar University (Deemed to be University) | Conditions: Pulpitis - Irreversible | Phase 4 | Status: COMPLETED